3 Recruiting Cognitive Dysfunction Phase 2 Clinical Trials

Active phase 2 studies for cognitive dysfunction enrolling across the USA. Verify eligibility and contact site coordinators.

All Cognitive Dysfunction studies

Phase 2 Studies for Cognitive Dysfunction

🟢 Recruiting Phase2

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

📍 TrialSphere Corp — Chandler, Arizona

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Stem Cell Therapy for Early Alzheimer's Disease

📍 The University of Texas Health Science Center at Houston (UTHealth) — Houston, Texas

View Study & Checklist ➔

🟢 Recruiting Phase2

ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults

📍 Rutgers - Institute for Health — New Brunswick, New Jersey

View Study & Checklist ➔